6 weeks on tirzepatide and no weight loss ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide Weight Loss Timeline: When

However, the FDA has not approved retatrutide for any indication

Adults are generally advised to aim for at least 150 minutes of moderate physical activity per week

Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory

Besides its outstanding weight loss effect, this drug can also significantly improve blood sugar control and lower lipid levels, providing a new treatment option for obese and type 2 diabetic patients

Hepatorenal syndrome is almost always accompanied by ascites and can lead to rapid (type I hepatorenal syndrome) or slowly progressing (type II hepatorenal syndrome) kidney failure (Lata 2012)